NO169442C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive prolinderivater og lignende forbindelser - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive prolinderivater og lignende forbindelserInfo
- Publication number
- NO169442C NO169442C NO853551A NO853551A NO169442C NO 169442 C NO169442 C NO 169442C NO 853551 A NO853551 A NO 853551A NO 853551 A NO853551 A NO 853551A NO 169442 C NO169442 C NO 169442C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- similar compounds
- proline derivatives
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/649,797 US4746676A (en) | 1984-09-12 | 1984-09-12 | Carboxyalkyl dipeptide compounds |
| US06/752,695 US4749698A (en) | 1985-07-08 | 1985-07-08 | Antihypertensive derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO853551L NO853551L (no) | 1986-03-13 |
| NO169442B NO169442B (no) | 1992-03-16 |
| NO169442C true NO169442C (no) | 1992-06-24 |
Family
ID=27095707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO853551A NO169442C (no) | 1984-09-12 | 1985-09-11 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive prolinderivater og lignende forbindelser |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0175266B1 (ko) |
| KR (1) | KR860002464A (ko) |
| AT (1) | ATE135711T1 (ko) |
| AU (1) | AU578489B2 (ko) |
| CA (1) | CA1288893C (ko) |
| DE (1) | DE3588094T2 (ko) |
| DK (1) | DK412985A (ko) |
| ES (1) | ES8609364A1 (ko) |
| FI (1) | FI89716C (ko) |
| IL (1) | IL76345A (ko) |
| IN (1) | IN164615B (ko) |
| NO (1) | NO169442C (ko) |
| NZ (1) | NZ213432A (ko) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629345A (en) * | 1993-07-23 | 1997-05-13 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
| US5965620A (en) * | 1993-07-23 | 1999-10-12 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
| EP0765341A4 (en) * | 1994-06-16 | 1998-09-16 | Smithkline Beecham Corp | CYCLISATION DIRECTED BY MATRIX |
| IL148972A0 (en) † | 1999-10-14 | 2002-11-10 | Curis Inc | Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| DE50015940D1 (de) | 2000-09-21 | 2010-07-29 | Abb Schweiz Ag | Konfiguration eines Leitsystems einer elektrischen Schaltanlage |
| ES2443242T3 (es) | 2005-12-23 | 2014-02-18 | Zealand Pharma A/S | Compuestos modificados miméticos de lisina |
| PL2468724T3 (pl) | 2006-12-21 | 2016-05-31 | Zealand Pharma As | Synteza związków pirolidynowych |
| EP3618847B1 (en) | 2017-05-05 | 2021-04-07 | Zealand Pharma A/S | Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5683483A (en) * | 1979-12-13 | 1981-07-08 | Santen Pharmaceut Co Ltd | Thiazolidine compound |
| US4350704A (en) * | 1980-10-06 | 1982-09-21 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids |
| EP0048159A3 (en) * | 1980-09-17 | 1982-05-12 | University Of Miami | Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents |
| US4462943A (en) * | 1980-11-24 | 1984-07-31 | E. R. Squibb & Sons, Inc. | Carboxyalkyl amino acid derivatives of various substituted prolines |
| FR2501399B1 (fr) * | 1981-03-03 | 1987-06-19 | France Etat | Dispositif d'affichage de messages graphiques transmis par des systemes de videotex |
| EP0080822A1 (en) * | 1981-11-27 | 1983-06-08 | Beecham Group Plc | Anti-hypertensive prolinol-based peptides |
| EP0088350B1 (en) * | 1982-03-08 | 1985-02-20 | Schering Corporation | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| ZA832762B (en) * | 1982-04-30 | 1983-12-28 | Squibb & Sons Inc | Substituted 4-phenoxy prolines |
| AU1643283A (en) * | 1982-07-19 | 1984-01-26 | E.R. Squibb & Sons, Inc. | Substituted peptides |
| US4623729A (en) * | 1982-07-22 | 1986-11-18 | E. R. Squibb & Sons, Inc. | Acylalkylaminocarbonyl substituted amino and imino acid compounds |
| US4499079A (en) * | 1982-11-18 | 1985-02-12 | E. R. Squibb & Sons, Inc. | Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides |
| DK156484A (da) * | 1983-03-16 | 1984-09-17 | Usv Pharma Corp | Aminosyrederivater |
| AU2859984A (en) * | 1983-05-23 | 1984-11-29 | Usv Pharmaceutical Corp. | Compounds for treating hypertension |
-
1985
- 1985-09-10 AT AT85111454T patent/ATE135711T1/de not_active IP Right Cessation
- 1985-09-10 AU AU47331/85A patent/AU578489B2/en not_active Ceased
- 1985-09-10 DE DE3588094T patent/DE3588094T2/de not_active Expired - Fee Related
- 1985-09-10 EP EP85111454A patent/EP0175266B1/en not_active Expired - Lifetime
- 1985-09-10 IL IL76345A patent/IL76345A/xx unknown
- 1985-09-11 NZ NZ213432A patent/NZ213432A/xx unknown
- 1985-09-11 NO NO853551A patent/NO169442C/no unknown
- 1985-09-11 DK DK412985A patent/DK412985A/da not_active Application Discontinuation
- 1985-09-11 ES ES546866A patent/ES8609364A1/es not_active Expired
- 1985-09-11 KR KR1019850006633A patent/KR860002464A/ko not_active Application Discontinuation
- 1985-09-11 CA CA000490437A patent/CA1288893C/en not_active Expired - Lifetime
- 1985-09-12 FI FI853494A patent/FI89716C/fi not_active IP Right Cessation
- 1985-09-16 IN IN652/CAL/85A patent/IN164615B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ213432A (en) | 1988-11-29 |
| CA1288893C (en) | 1991-09-10 |
| AU578489B2 (en) | 1988-10-27 |
| FI853494L (fi) | 1986-03-13 |
| IN164615B (ko) | 1989-04-22 |
| EP0175266B1 (en) | 1996-03-20 |
| FI853494A0 (fi) | 1985-09-12 |
| NO853551L (no) | 1986-03-13 |
| DK412985D0 (da) | 1985-09-11 |
| EP0175266A2 (en) | 1986-03-26 |
| IL76345A (en) | 1988-12-30 |
| DK412985A (da) | 1986-03-13 |
| FI89716B (fi) | 1993-07-30 |
| AU4733185A (en) | 1986-03-20 |
| ES546866A0 (es) | 1986-07-16 |
| FI89716C (fi) | 1993-11-10 |
| DE3588094D1 (de) | 1996-04-25 |
| NO169442B (no) | 1992-03-16 |
| DE3588094T2 (de) | 1996-08-22 |
| ATE135711T1 (de) | 1996-04-15 |
| ES8609364A1 (es) | 1986-07-16 |
| IL76345A0 (en) | 1986-01-31 |
| KR860002464A (ko) | 1986-04-26 |
| EP0175266A3 (en) | 1988-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO167142C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| NO159089C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater. | |
| NO853046L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
| NO172540C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrrolderivater | |
| NO871879D0 (no) | Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser. | |
| NO164097C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. | |
| NO169485C (no) | Analogifremgangsmaate til fremstilling av farmakologisk aktive, substituerte benzamidderivater | |
| NO166083C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater. | |
| NO165841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater. | |
| NO161564C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater. | |
| ATE81653T1 (de) | Dideoxydidehydrocarbocyclische nukleoside. | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO169442C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive prolinderivater og lignende forbindelser | |
| NO164020C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater. | |
| DK521685D0 (da) | Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning | |
| NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
| ES8602631A1 (es) | Procedimiento de producir compuestos para tratar la hipertension | |
| NO163330C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater. | |
| NO162072C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater. | |
| NO862390D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. | |
| NO171499C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivater | |
| NO162820C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolpyridin- eller benzimidazolderivater. | |
| NO165295C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater. | |
| NO157575C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridin-derivater. | |
| ES2033859T3 (es) | Acidos y esteres 2-amino-3-aroil-gamma-oxobencenbutanoicos. |